# Effect of Hydrocortison on Post-ischemic Flow-mediated Dilation and on Thenar Oxygen Saturation in Human Septic Shock.

> **NCT01817153** · PHASE2,PHASE3 · TERMINATED · sponsor: **Centre Hospitalier Régional d'Orléans** · enrollment: 10 (actual)

## Conditions studied

- Septic Shock
- Adult

## Interventions

- **DRUG:** hydrocortison hemisuccinate
- **DRUG:** placebo followed by hydrocortisone hemisuccinate

## Key facts

- **NCT ID:** NCT01817153
- **Lead sponsor:** Centre Hospitalier Régional d'Orléans
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-11-05
- **Primary completion:** 2019-11-05
- **Final completion:** 2019-11-05
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** not enough recruitment
- **Last updated:** 2020-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01817153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01817153, "Effect of Hydrocortison on Post-ischemic Flow-mediated Dilation and on Thenar Oxygen Saturation in Human Septic Shock.". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT01817153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*